Medulloblastome im Kindes- und Jugendalter im Zeitraum von 1989 bis 2015

Diouf, Sarah Maimouna

Klinisches Management und chirurgisches Outcome an der Universitätsmedizin Göttingen

dc.contributor.advisor	Ludwig, Hans-Christoph Prof. Dr.
dc.contributor.author	Diouf, Sarah Maimouna
dc.date.accessioned	2022-02-22T15:35:43Z
dc.date.available	2022-03-10T00:50:06Z
dc.date.issued	2022-02-22
dc.identifier.uri	http://resolver.sub.uni-goettingen.de/purl?ediss-11858/13878
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-46
dc.language.iso	deu	de
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.subject.ddc	610	de
dc.title	Medulloblastome im Kindes- und Jugendalter im Zeitraum von 1989 bis 2015	de
dc.title.alternative	Klinisches Management und chirurgisches Outcome an der Universitätsmedizin Göttingen
dc.type	doctoralThesis	de
dc.title.translated	Medulloblastomas in children and adolescents from 1989 to 2015	de
dc.contributor.referee	Kramm, Christof Prof. Dr.
dc.date.examination	2022-03-03	de
dc.description.abstracteng	Medulloblastoma is the most common malignant brain tumor in children and adolescents and its therapy is still difficult due to the vulnerability of the child's brain. Medulloblastomas arise in the posterior fossa of the cerebellum and can metastasize via the cerebrospinal fluid pathways. Despite aggressive treatments consisting of surgery, chemotherapy, and radiotherapy, medulloblastomas remain incurable in many patients. In the last few decades, better and better survival rates have been achieved through ever more specific therapeutic approaches, but many of the patients continue to die or suffer from tumor- or therapy-related long-term sequelae. It is crucial for a favorable prognosis to identify high-risk patients as early as possible, to provide them with an appropriate therapy and, if necessary, to initiate an early intensification of therapy. The present work represents a monocentric, retrospective study of the clinical course of all pediatric patients in whom a medulloblastoma was initially diagnosed between 1989 and 2015 at the Universitätsmedizin Göttingen by neurosurgical surgery with subsequent histopathological work-up. For this purely institutional patient collective, the prognostic significance of different influencing factors such as age, tumor extent, surgical management, extent of tumor resection and the histopathological subclassification on the long-term therapy result with regard to the endpoints progression-free and overall survival should be examined.	de
dc.contributor.coReferee	Meyer, Thomas Prof. Dr.
dc.subject.eng	medulloblastoma	de
dc.identifier.urn	urn:nbn:de:gbv:7-ediss-13878-7
dc.affiliation.institute	Medizinische Fakultät	de
dc.subject.gokfull	:Nachschlagewerke {Medizin} (PPN620300566)	de
dc.description.embargoed	2022-03-10	de
dc.identifier.ppn	1794694927

Files in this item

Name:eDISS Sarah Maimouna Diouf 2022.pdf

Size:844.0Kb

Format:PDF

View/Open

Name:: eDISS Sarah Maimouna Diouf 2022.pdf
Size:: 844.0Kb
Format:: PDF

View/Open

This item appears in the following Collection(s)

Human- und Zahnmedizin [2663]

Show simple item record